Use of Oxandrolone to Promote Growth in Infants With HLHS

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

September 19, 2023

Study Completion Date

September 19, 2023

Conditions
Hypoplastic Left HeartCongenital Heart Disease
Interventions
DRUG

Oxandrolone

Oxandrolone 2.5mg tabs will be suspended in multi-chain triglyceride (MCT) oil and administered buccally.

Trial Locations (10)

19104

Children's Hospital of Philadelphia, Philadelphia

29425

Medical University of South Carolina, Charleston

30322

Children's Hospital of Atlanta, Atlanta

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

48109

University of Michigan Health System, Ann Arbor, Ann Arbor

76104

Cook Children's Medical Center, Fort Worth

77030

Texas Children's Hospital, Houston

84113

Primary Children's Medical Center, Salt Lake City

02115

Boston Children's Hospital, Boston

M5G 1X8

The Hospital for Sick Children, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Carelon Research

OTHER

NCT04090697 - Use of Oxandrolone to Promote Growth in Infants With HLHS | Biotech Hunter | Biotech Hunter